IP Library Granted Patent US 9,533,073
Granted Patent B1
US 9,533,073 · App. 14/709,726 · Granted Jan 3, 2017

Microvascular stamp for patterning of functional neovessels

Inventors: Hyunjoon Kong (Champaign, IL); Rashid Bashir (Champaign, IL); Jaehyun Jeong (Champaign, IL); Vincent Chan (Urbana, IL); Chaenyung Cha (Penndel, PA); Pinar Zorlutuna (Cambridge, MA)
Assignee: The Board of Trustees of the University of Illinois
A61L27/507A61L27/26A61L27/3834A61L27/52A61L27/54A61L2300/64A61L2430/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,533,073
App. No.
14/709,726
Granted
Jan 3, 2017
Kind
B1
Abstract

The invention provides compositions and methods for making and using microvascular stamps for stimulation and spatial organization of neovessels in tissue.

Claims (12)

1. A method of inducing growth of new blood vessels in a tissue comprising contacting one or more microvascular stamps comprising one or more types of cells encapsulated in a poly(ethylene glycol) (PEGDA) and methacrylic polymer cross-linked hydrogel with the tissue, wherein the cross-linked hydrogel comprises microchannels, wherein the new blood vessels are localized within the lumina of the microchannels, and wherein the one or more microvascular stamps induce growth of new blood vessels in the tissue.

2. The method of claim 1 , wherein the one or more types of cells express one or more fusion proteins comprising a growth factor, proangiogenic factor, or antiangiogenic factor fused to a protein light switch.

3. The method of claim 2 , wherein the one or more microvascular stamps are illuminated with light at a wavelength of about 450 nm to about 500 nm.

4. The method of claim 1 , wherein microscale spacing between the new blood vessels is regulated by microchannel diameter and spacing.

5. The method of claim 1 , wherein the microscale spacing between the new blood vessels is about 100 μm to about 2.5 mm on-center.

6. The method of claim 1 , wherein the one or more types of cells secrete one or more proangiogenic factors, growth factors, or antiangiogenic factors.

7. The method of claim 1 , wherein the microchannels are about 100 μm to about 2.5 mm in diameter and wherein the on-center spacing between the microchannels is about 100 μm to about 2.5 mm.

8. The method of claim 1 , wherein the ratio between the flux of growth factors through a microchannel wall of the one or more microvascular stamps (J m ) is larger than the flux through a bottom of the one or more microvascular stamps with the same cross-sectional area as the microchannel (J r ).

9. The method of claim 1 , wherein the one or more microvascular stamps are about 100 μm to about 5 mm thick.

10. The method of claim 1 , wherein the one or more microvascular stamps have an elastic modulus of about 10 kPa to about 140 kPa.

11. The method of claim 1 , wherein the tissue is in vivo.

12. The method of claim 11 , wherein the tissue has a defect and the one or more microvascular stamps are contacted with the defect.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 15, 2020
From: UNIVERSITY OF ILLINOIS, URBANA-CHAMPAIGN
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 053782/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2015
From: KONG, HYUNJOON; BASHIR, RASHID; JEONG, JAEHYUN; CHAN, VINCENT; CHA, CHAENYUNG; ZORLUTUNA, PINAR
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 035617/0426 →
Continuity (2)
Continuation 13788023 · Mar 7, 2013
Provisional Application 61650073 · May 22, 2012